VOR Competitors & Alternatives

Compare Vor Biopharma Inc with similar stocks in the same industry

Biotechnology

VOR

Main Stock
$19.26
-0.82%
Tradestie Score
58
Market Cap
$269.08M
P/E Ratio
0.1
Analyst Upside
+102.5%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Cell Therapy
Competitive Moat: None
Core Technology Stack: Engineered hematopoietic stem cells, Gene editing for eHSCs, CAR-T combinations
Major Customers 3
Academic medical centers Clinical trial sites Blood cancer treatment centers
Critical Suppliers 3
Gene editing technology providers Cell manufacturing CDMOs CRISPR reagents suppliers
Direct Ecosystem Rivals 4

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CVAC CureVac N.V. Ordinary Shares
$4.66
-0.21%
$1.22B 7.0 54 Compare
ATAI ATAI Life Sciences N.V. Common Shares
$7.35
+0.82%
$1.22B - 44 Compare
PGEN Precigen, Inc. Common Stock
$4.33
-4.63%
$1.18B 42.4 60 Compare
ELVN Enliven Therapeutics, Inc. Common Stock
$47.74
-2.18%
$1.17B - 34 Compare
INVA Innoviva, Inc. Common Stock
$18.59
-2.34%
$1.15B 8.1 54 Compare
TRVI Trevi Therapeutics, Inc. Common Stock
$13.30
-2.56%
$1.14B - 42 Compare
ORIC Oric Pharmaceuticals, Inc. Common Stock
$7.69
-2.23%
$1.14B - 45 Compare
MAZE Maze Therapeutics, Inc. Common Stock
$34.16
-0.50%
$1.13B - 32 Compare
WVE Wave Life Sciences Ltd. Ordinary Shares
$2.89
-7.82%
$1.12B - 32 Compare
NKTR Nektar Therapeutics
$36.57
-1.88%
$1.12B - 59 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

216 stocks in this industry